Morgan Joseph Reiterates a 'Buy' on Nektar Therapeutics (NKTR)
Tweet Send to a Friend
Morgan Joseph reiterates a 'Buy' on Nektar Therapeutics (Nasdaq: NKTR), price target $12.
Morgan analyst says, "While Nektar Therapeutics continues ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "While Nektar Therapeutics continues ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
